India, April 18 -- U.S. President Donald Trump signed a sweeping executive order aimed at accelerating research into psychedelic drugs and marking a significant shift in federal mental health policy. The initiative includes $50 million in funding and new regulatory changes designed to speed up clinical trials and expand treatment access.

What is Ibogaine

Ibogaine is a naturally occurring psychedelic compound derived from the root bark of the Tabernanthe iboga, traditionally used in spiritual ceremonies in Gabon and nearby regions where researchers are studying ibogaine for its potential to treat addiction, depression and Post-Traumatic Stress Disorder. Early studies suggest it may reduce withdrawal symptoms and cravings, but it remains ...